How Cancer Treatment Accelerates Aging
Cancer treatment is designed to destroy rapidly dividing cells — but the collateral damage extends far beyond the tumor. Chemotherapy induces widespread DNA damage, accelerates cellular senescence, depletes stem cell reserves, and drives mitochondrial dysfunction. Radiation causes localized tissue damage and systemic inflammation. Hormone therapies (tamoxifen, aromatase inhibitors, androgen deprivation) alter the hormonal milieu in ways that accelerate bone loss, cardiovascular aging, and metabolic dysfunction.
Some of these effects can be measured. Adult survivors of childhood cancer show faster epigenetic aging than people who never had cancer, especially after chest or abdominal radiation and some chemotherapy drugs.1 Heart disease is a major threat: in a US study of more than 3 million cancer patients, about 11 percent died of cardiovascular disease, and in eight cancer types the yearly risk of cardiovascular death at some point exceeded the risk of dying from the original cancer.2
After treatment, the goals are to lower the risk of the cancer returning and to repair or prevent treatment damage. Exercise now has randomized evidence for the first goal in colon cancer (below). Healthy weight, diet and alcohol limits are reasonable bets for both goals, based mostly on observational studies.6
Exercise: The Most Important Survivorship Intervention
Exercise has the strongest evidence of any lifestyle measure for survivors. An international roundtable convened by the American College of Sports Medicine concluded that exercise is generally safe for survivors and that every survivor should avoid inactivity, and that specific doses of aerobic and resistance exercise improve anxiety, depression, fatigue, physical function and quality of life.3
Recurrence. In the CHALLENGE trial, 889 people who had finished chemotherapy for colon cancer were assigned to a three-year structured exercise program or to health-education materials. After a median of 7.9 years, the exercise group had a 28 percent lower risk of recurrence, a new cancer or death (5-year disease-free survival 80.3 vs 73.9 percent) and a 37 percent lower risk of death.4 For breast and prostate cancer, the evidence is still observational.
Rebuilding muscle. Treatment speeds muscle loss through inactivity, inflammation and hormone changes. Resistance training two or three times a week pushes back; start with bodyweight or light loads and progress gradually.
Protecting the heart. Anthracyclines such as doxorubicin and chest radiation can damage the heart. Aerobic exercise is part of protecting it, but if you had cardiotoxic treatment, agree on intensity with your oncologist or a cardio-oncologist before starting a hard program.
Thinking and memory. Whether exercise helps with cancer-related cognitive problems ("chemo brain") is still being studied. Treat any benefit as a likely bonus of staying active rather than a proven treatment.
Nutrition and Metabolic Optimization
Maintain a healthy weight. Obesity is linked to worse outcomes after several cancers: in a meta-analysis of 82 studies of breast cancer survivors, women with obesity before diagnosis had 41 percent higher total mortality than normal-weight women.5 If you are carrying extra weight after treatment, lose it gradually and keep up protein and strength training so the loss comes from fat rather than muscle.
A healthy eating pattern. Build meals around vegetables, fruits, legumes, whole grains, fish and olive oil, and keep processed meat, sugary drinks and ultra-processed foods to a minimum; the American Cancer Society notes that diet may affect recurrence and survival, although the evidence is mostly observational.6
Protein at every meal. Enough protein, spread across meals, helps rebuild muscle lost during treatment, especially alongside strength training.
Limit alcohol. Each daily drink raises the risk of developing breast cancer by about 7 percent.7 Its effect on recurrence is less certain, but cutting back is one of the simplest changes a survivor can make.
Testing and Monitoring for Survivorship Longevity
Cancer surveillance — Follow your oncologist's recommended screening schedule for recurrence monitoring. This is non-negotiable and cancer-type-specific.
Cardiovascular monitoring — If you had an anthracycline or chest radiation, ask whether you need heart imaging. Keep up with blood pressure and cholesterol checks: in the US study above, the risk of cardiovascular death was highest in the first year after diagnosis (nearly four times the general population's) and stayed elevated afterward.2
Bone density (DEXA) — Aromatase inhibitors, androgen deprivation therapy and treatment-induced menopause speed bone loss, so ask about a baseline scan and how often to repeat it.
Metabolic panel — HbA1c, fasting glucose and lipids. Some treatments, including steroids and hormone therapies, can push blood sugar and weight in the wrong direction, so track them and act early.
Thyroid function — In a systematic review, 23 to 53 percent of people treated with radiation for head and neck cancer developed hypothyroidism,8 so check TSH and free T4 regularly if your neck was irradiated.
Supplements with Survivorship Evidence
Vitamin D — Correct a deficiency, but don't count on vitamin D to prevent recurrence. In VITAL, vitamin D did not lower cancer incidence.9 In SUNSHINE, a small phase 2 trial in advanced colorectal cancer, high-dose vitamin D modestly extended progression-free survival in an adjusted analysis.10 In AMATERASU, it did not significantly improve relapse-free survival in digestive tract cancers.11
Omega-3 fatty acids — Eating fatty fish fits a healthy pattern, but there is no good evidence that omega-3 supplements prevent recurrence.
Curcumin — Despite promising lab studies, no trial has shown that curcumin prevents recurrence. Ask your oncologist before taking it alongside any cancer drug.
Avoid antioxidant supplements during treatment. In a study of women receiving chemotherapy for breast cancer, those who took antioxidant supplements (vitamins A, C and E, carotenoids or coenzyme Q10) both before and during treatment had a higher risk of recurrence; the result was borderline, but it is reason enough for caution.12 Ask your oncologist before restarting supplements after treatment.
Sleep — Sleep problems are common after treatment. Start with consistent sleep habits and ask your care team about insomnia treatment; if you try melatonin, use a low dose and tell them.
References
- 1Qin N, et al. "Epigenetic Age Acceleration and Chronic Health Conditions Among Adult Survivors of Childhood Cancer." J Natl Cancer Inst. 2021;113(5):597-605. PubMed · DOI
- 2Sturgeon KM, et al. "A population-based study of cardiovascular disease mortality risk in US cancer patients." Eur Heart J. 2019;40(48):3889-3897. PubMed · DOI
- 3Campbell KL, et al. "Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable." Med Sci Sports Exerc. 2019;51(11):2375-2390. PubMed · DOI
- 4Courneya KS, et al. "Structured Exercise after Adjuvant Chemotherapy for Colon Cancer." N Engl J Med. 2025;393(1):13-25. PubMed · DOI
- 5Chan DSM, et al. "Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies." Ann Oncol. 2014;25(10):1901-1914. PubMed · DOI
- 6Rock CL, et al. "American Cancer Society nutrition and physical activity guideline for cancer survivors." CA Cancer J Clin. 2022;72(3):230-262. PubMed · DOI
- 7Hamajima N, et al. "Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease." Br J Cancer. 2002;87(11):1234-45. PubMed · DOI
- 8Boomsma MJ, et al. "Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review." Radiother Oncol. 2011;99(1):1-5. PubMed · DOI
- 9Manson JE, et al. "Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease." N Engl J Med. 2019;380(1):33-44. PubMed · DOI
- 10Ng K, et al. "Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial." JAMA. 2019;321(14):1370-1379. PubMed · DOI
- 11Urashima M, et al. "Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial." JAMA. 2019;321(14):1361-1369. PubMed · DOI
- 12Ambrosone CB, et al. "Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)." J Clin Oncol. 2020;38(8):804-814. PubMed · DOI
Frequently Asked Questions
Some treatments appear to. Adult survivors of childhood cancer show faster epigenetic aging than people who never had cancer, particularly after chest or abdominal radiation and some chemotherapy drugs. How far this applies to adults treated later in life is less clear.
For colon cancer, yes: in the CHALLENGE trial, a structured exercise program after chemotherapy cut the risk of recurrence, a new cancer or death by 28 percent and the risk of death by 37 percent. For breast and prostate cancer, the evidence comes from observational studies, which also link activity to better outcomes.
Antioxidant supplements taken before and during chemotherapy were linked to a higher risk of breast cancer recurrence in one large study, so avoid them during treatment. After treatment, correct any deficiency (vitamin D, for example) and check other supplements with your oncologist; none has been shown to prevent recurrence.
Cancer survivors need both cancer-specific surveillance AND longevity-focused screening. Treatment-related cardiovascular monitoring (echo if anthracycline-exposed), bone density (if hormone therapy), thyroid function (if neck radiation), and standard longevity biomarkers.